Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)
Latest Information Update: 17 Sep 2024
Price :
$35 *
At a glance
- Drugs Allopurinol (Primary) ; Mannitol
- Indications Brain hypoxia-ischaemia
- Focus Pharmacodynamics
- Acronyms ALBINO
- 20 Apr 2024 This trial has been Discontinued in Germany, according to European Clinical Trials Database record.
- 24 Jan 2024 Detailed statistical analysis plan for ALBINO, published in the Trials
- 07 Jul 2023 Planned number of patients changed from 846 to 760.